Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Clinical trial NCT07601425 · RECRUITING

Trial details

NCT number: NCT07601425
Sponsor: Atavistik Bio, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia (HHT)Osler Weber Rendu Disease

Start date: 2026-07-27
Primary completion: 2027-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.